Genentech’s Actemra gets FDA approval to begin COVID-19 Trials in April
By Ruchi Jhonsa, Ph.D. While we are still waiting on the clinical trial data of Gilead’s remdesivir, Genentech bags approval from the FDA to test Actemra (tocilizumab) in adult patients …
Read More